Nelson L. Michael

1995–2025 年に発表

別表記
Nelson L Michael
179
論文数
28,865
被引用数
94
h 指数
175
i10 指数

被引用数

Nelson L. Michael の年別被引用数1986 年: 被引用 1 件1993 年: 被引用 1 件1996 年: 被引用 4 件1997 年: 被引用 35 件1998 年: 被引用 67 件1999 年: 被引用 64 件2000 年: 被引用 39 件2001 年: 被引用 65 件2002 年: 被引用 59 件2003 年: 被引用 55 件2004 年: 被引用 48 件2005 年: 被引用 53 件2006 年: 被引用 54 件2007 年: 被引用 38 件2008 年: 被引用 31 件2009 年: 被引用 34 件2010 年: 被引用 112 件2011 年: 被引用 141 件2012 年: 被引用 163 件2013 年: 被引用 219 件2014 年: 被引用 283 件2015 年: 被引用 264 件2016 年: 被引用 264 件2017 年: 被引用 376 件2018 年: 被引用 299 件2019 年: 被引用 1,157 件2020 年: 被引用 1,293 件2021 年: 被引用 1,054 件2022 年: 被引用 805 件2023 年: 被引用 505 件2024 年: 被引用 812 件2025 年: 被引用 341 件2026 年: 被引用 1 件1987〜1992 年は被引用が無いため表示していません1994〜1995 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 3,273 件、この内訳の 34.5%イギリス: 引用元論文 676 件、この内訳の 7.1%中国: 引用元論文 468 件、この内訳の 4.9%カナダ: 引用元論文 407 件、この内訳の 4.3%ドイツ: 引用元論文 354 件、この内訳の 3.7%フランス: 引用元論文 325 件、この内訳の 3.4%南アフリカ: 引用元論文 321 件、この内訳の 3.4%オランダ: 引用元論文 289 件、この内訳の 3.1%オーストラリア: 引用元論文 281 件、この内訳の 3%スイス: 引用元論文 234 件、この内訳の 2.5%イタリア: 引用元論文 228 件、この内訳の 2.4%スペイン: 引用元論文 212 件、この内訳の 2.2%
0%34.5%その他 25.5%

分野

  • Medicine44.9%
  • Immunology and Microbiology42.4%
  • Biochemistry, Genetics and Molecular Biology9.2%
  • Neuroscience0.5%
  • Agricultural and Biological Sciences0.5%
  • Engineering0.3%
  • その他2.2%

トピック

  • HIV Research and Treatment14.1%
  • Immune Cell Function and Interaction6.3%
  • SARS-CoV-2 and COVID-19 Research5.9%
  • HIV/AIDS Research and Interventions4.9%
  • HIV/AIDS drug development and treatment4.1%
  • T-cell and B-cell Immunology3.3%
  • その他61.4%

共著者

全論文

検索で開く
  1. SARS-CoV-2 Variants in Patients with Immunosuppression

    著者: , , , , , - New England Journal of Medicine 2021 被引用: 474

  2. Vaccination with ALVAC and AIDSVAX to Prevent HIV-1 Infection in Thailand

    著者: , , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2009 被引用: 3,028

  3. Immune-Correlates Analysis of an HIV-1 Vaccine Efficacy Trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Phillip W. Berman, Nicole Frahm, Stephen C. De Rosa, Michael D. Alpert, Nicole L. Yates, Xiaoying Shen, Richard A. Koup, Punnee Pitisuttithum, Jaranit Kaewkungwal, Sorachai Nitayaphan, Supachai Rerks‐Ngarm, Nelson L. Michael, Jérôme H. Kim - New England Journal of Medicine 2012 被引用: 1,834

  4. Evaluation of a mosaic HIV-1 vaccine in a multicentre, randomised, double-blind, placebo-controlled, phase 1/2a clinical trial (APPROACH) and in rhesus monkeys (NHP 13-19)

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Frances Priddy, Erica Lazarus, Fatima Laher, Sorachai Nitayapan, Punnee Pitisuttithum, Stephan Bart, Thomas Campbell, Robert Feldman, Gregg Lucksinger, Caroline Borremans, Katleen Callewaert, Raphaele Roten, Jerald Sadoff, Lorenz Scheppler, Mo Weijtens, Karin Feddes-de Boer, Daniëlle van Manen, Jessica Vreugdenhil, Roland Zahn, Ludo Lavreys, Steven Nijs, Jeroen Tolboom, Jenny Hendriks, Zelda Euler, Maria Grazia Pau, Hanneke Schuitemaker - The Lancet 2018 被引用: 342

  5. SARS-CoV-2 ferritin nanoparticle vaccines elicit broad SARS coronavirus immunogenicity

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ousman Jobe, Vincent Dussupt, Sebastian Molnar, Ursula Tran, Chandrika B. Kannadka, Sandrine Soman, Caitlin Kuklis, Michelle Zemil, Htet Khanh, Weimin Wu, Matthew Cole, Debra K. Duso, Larry Kummer, Tricia J. Lang, Shania E. Muncil, Jeffrey R. Currier, Shelly J. Krebs, Victoria R. Polonis, Saravanan Rajan, Patrick M. McTamney, Mark T. Esser, William W. Reiley, Morgane Rolland, Natalia de Val, Michael Diamond, Gregory D. Gromowski, Gary R. Matyas, Mangala Rao, Nelson L. Michael, Kayvon Modjarrad - Cell Reports 2021 被引用: 186

  6. A SARS-CoV-2 ferritin nanoparticle vaccine elicits protective immune responses in nonhuman primates

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Manoj S. Nair, Vincent Dussupt, Sharon P. Daye, Xiankun Zeng, Erica K. Barkei, Hilary Staples, Kendra J. Alfson, Ricardo Carrion, Shelly J. Krebs, Dominic Paquin‐Proulx, Nicos Karasavva, Victoria R. Polonis, Linda L. Jagodzinski, Mihret F. Amare, Sandhya Vasan, Paul T. Scott, Yaoxing Huang, David D. Ho, Natalia de Val, Michael Diamond, Mark G. Lewis, Mangala Rao, Gary R. Matyas, Gregory D. Gromowski, Sheila A. Peel, Nelson L. Michael, Diane L. Bolton, Kayvon Modjarrad - Science Translational Medicine 2022 被引用: 145

  7. Central Nervous System Viral Invasion and Inflammation During Acute HIV Infection

    著者: , , , , , , , , , , , , , - The Journal of Infectious Diseases 2012 被引用: 533

  8. Rapid HIV RNA rebound after antiretroviral treatment interruption in persons durably suppressed in Fiebig I acute HIV infection

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Nature Medicine 2018 被引用: 333

  9. Dissecting Polyclonal Vaccine-Induced Humoral Immunity against HIV Using Systems Serology

    著者: , , , , , , , , , , , , , , , , , , , , , - Cell 2015 被引用: 371

  10. Rapid seeding of the viral reservoir prior to SIV viraemia in rhesus monkeys

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , - Nature 2014 被引用: 635

  11. COMPASS identifies T-cell subsets correlated with clinical outcomes

    著者: , , , , , , , , , , , , , , , , , , , , , , , , - Nature Biotechnology 2015 被引用: 291

  12. Recommendations for analytical antiretroviral treatment interruptions in HIV research trials—report of a consensus meeting

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jessica Salzwedel, Karl Salzwedel, Timothy W. Schacker, Virginia Sheikh, Ole S. Søgaard, Serena Spudich, Kathryn E. Stephenson, Jeremy Sugarman, Jeff Taylor, Pablo Tebas, Caroline T. Tiemessen, Randall Tressler, Carol D. Weiss, Lu Zheng, Merlin L. Robb, Nelson L. Michael, John W. Mellors, Steven G. Deeks, Bruce D. Walker - The Lancet HIV 2019 被引用: 206

  13. Persistent, Albeit Reduced, Chronic Inflammation in Persons Starting Antiretroviral Therapy in Acute HIV Infection

    著者: , , , , , , , , , , , , , , , - Clinical Infectious Diseases 2016 被引用: 264

  14. Vaccine-Induced Env V1-V2 IgG3 Correlates with Lower HIV-1 Infection Risk and Declines Soon After Vaccination

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Georgia D. Tomaras - Science Translational Medicine 2014 被引用: 454

  15. Safety and immunogenicity of an anti-Middle East respiratory syndrome coronavirus DNA vaccine: a phase 1, open-label, single-arm, dose-escalation trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Gary Kobinger, Nelson L. Michael, David B. Weiner, Stephen J. Thomas, Joel N. Maslow - The Lancet Infectious Diseases 2019 被引用: 322

  16. Structure-guided drug design identifies a BRD4-selective small molecule that suppresses HIV

    著者: , , , , , , , , , , , , , - Journal of Clinical Investigation 2019 被引用: 84

  17. Polyfunctional Fc-Effector Profiles Mediated by IgG Subclass Selection Distinguish RV144 and VAX003 Vaccines

    著者: , , , , , , , , , , , , , , , , , , , , , , , , - Science Translational Medicine 2014 被引用: 408

  18. SARS-CoV-2 recombinant spike ferritin nanoparticle vaccine adjuvanted with Army Liposome Formulation containing monophosphoryl lipid A and QS-21: a phase 1, randomised, double-blind, placebo-controlled, first-in-human clinical trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Beza Gebrehana, Melissa E Greenleaf, Melinda J Hamer, Nathan K Jansen, Xiaotang Jing, Jael Kagai, Kamila Kourbanova, Michael A Koren, Monica L Martin, Kathryn McGuckin Wuertz, Jason A Regules, Aaron D Sanborn, David Wallace, Lei Zhu, Gregory D Gromowski, Courtney Corbitt, Janice M Darden, Vincent Dussupt, Emily S Golub, Jarrett A Headley, Umair M Jarral, Jocelyn King, Shelly J Krebs, Jenny Lay, Regina Lilly, Jennifer Lynch, Elizabeth J Martinez, Sandra V Mayer, Samantha McGeehon, Hyunna Lee, Steven Schech, Mekdi Tadesse, Paul V Thomas, Yahel Romem, Erifile Zografos, Bob C Lin, Sandeep R Narpala, Lingshu Wang, Nicole A Doria-Rose, Robin E Carroll, Amanda Eaton, Emily D Badraslioglu, Jason M Koontz, Ugo E Nwaeze, Peter Dawson, Alexander J Noll, Christine M Orndahl, Amy Bray, Ricardo Carrion, Jean Patterson, Viraj Kulkarni, Cory Hallam, Olga Gonzalez, Michal Gazi - The Lancet Microbe 2024 被引用: 53

  19. Longitudinal Analysis Reveals Early Development of Three MPER-Directed Neutralizing Antibody Lineages from an HIV-1-Infected Individual

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , L. Escudero Méndez, M. Anthony Moody, Anne Marie O’Sullivan, Christopher L. Owen, Dongjun Peng, Reda Rawi, Eric Sanders‐Buell, Chen‐Hsiang Shen, Andrea R. Shiakolas, Tyler Stephens, Yaroslav Tsybovsky, Courtney Tucker, Raffaello Verardi, Keyun Wang, Jing Zhou, Tongqing Zhou, George Georgiou, S. Munir Alam, Barton F. Haynes, Morgane Rolland, Gary R. Matyas, Victoria R. Polonis, Adrian B. McDermott, Daniel C. Douek, Lawrence Shapiro, Sodsai Tovanabutra, Nelson L. Michael, John R. Mascola, Merlin L. Robb, Peter D. Kwong, Nicole A. Doria‐Rose - Immunity 2019 被引用: 119

  20. SARS-CoV-2 ferritin nanoparticle vaccine induces robust innate immune activity driving polyfunctional spike-specific T cell responses

    著者: , , , , , , , , , , , , , , , , - npj Vaccines 2021 被引用: 75

  21. Protective efficacy of multiple vaccine platforms against Zika virus challenge in rhesus monkeys

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Mark G. Lewis, Galit Alter, Kayvon Modjarrad, Richard G. Jarman, Kenneth H. Eckels, Nelson L. Michael, Stephen J. Thomas, Dan H. Barouch - Science 2016 被引用: 504

  22. Ad26/MVA therapeutic vaccination with TLR7 stimulation in SIV-infected rhesus monkeys

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Nature 2016 被引用: 272

  23. Initiation of ART during Early Acute HIV Infection Preserves Mucosal Th17 Function and Reverses HIV-Related Immune Activation

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , - PLoS Pathogens 2014 被引用: 261

  24. Subtype C ALVAC-HIV and bivalent subtype C gp120/MF59 HIV-1 vaccine in low-risk, HIV-uninfected, South African adults: a phase 1/2 trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Peter B. Gilbert, Lawrence Corey, Glenda Gray, M. Juliana McElrath - The Lancet HIV 2018 被引用: 124